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ABSTRACT 
 
BACKGROUND: Gelukspan District Hospital is situated in the Ngaka Modiri 
Molema District in the North West Province. The majority of patients admitted 
in the adult medical wards of this Hospital are due to two conditions namely 
(a) HIV/ AIDS and (b) Cardio-metabolic diseases. The Hospital regularly 
analyse data related to the HIV/ AIDS patients for HIV/ AIDS conditional grant. 
The information related to cardio-metabolic diseases are seldom analysed by 
the Hospital management, although there is a belief within the Hospital that 
more than one thirds of the patients admitted in these two wards are due to 
cardio–metabolic diseases. This study was planned against this background 
to systematically analyse the routinely collected data from the Hospital 
information system. The results of the study would hopefully provide the 
estimation of the prevalence of these diseases at a health facility level and the 
cost for managing these conditions.   
AIM:  To describe the profiles of patients admitted of cardio–metabolic 
diseases in the Gelukspan District Hospital in the North West Province during 
one year study period (from 01 April 2010 to 31 March 2011).   
 METHODOLOGY: This was a cross-sectional study based on retrospective 
review of routinely collected data from the Adult Medical Wards of the 
Gelukspan District Hospital during the one year study period (1 April 2010 to 
31 March 2011). No primary data was collected for this study. The study 
variables included: the number of subjects with cardio-metabolic diseases 
among the subjects who were admitted in the Medical wards of the Hospital 
during one year study period; their profiles and the type and cost of laboratory 
tests performed for these patients at the time of admission. Permission to 
conduct the research at the Hospital was obtained from the North West 
Department of the Health and the University of the Witwatersrand ‘Human 
Research Ethics Committee (Medical) before commencement of the study.  
RESULTS: Number of admissions in male and female medical wards for non-
communicable diseases was 558. There were almost same number of female 
(n= 287) and male (271) admissions. The result showed that both males and 
females suffer equally from cardio-metabolic diseases. The age – group 
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analysis showed almost a third of the subjects were below 50 years age and 
another third was above 65 years of age. More than 20% of the population 
were pensioners representing the age distribution of the study cohort. The 
majority of the subjects were black (97.8%) and unemployed (98%) 
representing the demographics of the catchment population. The majority of 
the women were single (55.4%). There was no significant difference between 
male and female patients in terms of primary clinical diagnoses. Thirty-nine 
percent of the males (n=108) and 56% (163) females stayed more than 3 
days (the norms of average length of stay for District hospitals. The case 
fatality rate was 19.5% probably high in a district hospital setting, this implies 
that probably these patients were not managed properly at the PHC level and 
or at this The laboratory tests done at the time of admission included random 
and fasting blood glucose, and creatinine. No HbA1C, lipogram and other 
renal function tests were done at the time of admission contrary to the norms 
and guidelines for management of cardio-metabolic diseases. The laboratory 
test result showed the possibility of significant comorbidity among the patients. 
Fourteen percent of the subject probably had nephropathy.  
CONCLUSION: This was the first study conducted in this Hospital to 
systematically evaluate management of a particular group of patients. 
Hopefully, this study would assist the Hospital management to improve the 
management of patients admitted in this Hospital.  
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DEFINITION OF TERMS  
 
Cardio–metabolic disorders: Cardio-metabolic disorders represent a cluster of 
interrelated risk factors—primarily hypertension, elevated fasting glucose, 
dyslipidemia, abdominal obesity (waist circumference), and elevated 
triglycerides — that promote the development of atherosclerotic 
cardiovascular disease and type 2 diabetes. 
 
District Hospital:  A level one hospital offering primary health care services. 
 
Rural hospital: A hospital situated within the rural communities, having no 
municipal infrastructure (waste removal and bulk water supply). 
 
LIST OF ABBREVIATIONS   
 
CEO  Chief Executive Officer 
CHC  Community Health Centre 
CMD Cardio Metabolic Disease 
CVD Cardio-vascular diseases 
DHS District Health System  
DHIS District Health Information System 
GP  General Practitioner 
HOD Head of the Department 
NCD Non-Communicable diseases 
WHO World Health Organization 
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CHAPTER 1 
INTRODUCTION 
 
The purpose of this study was to describe the prevalence of cardio–metabolic 
diseases and associated costs of laboratory tests in a district hospital in the 
North West Province.  This introductory chapter will cover the background to 
the study, statement of the problem, aims and objectives as well as an outline 
of subsequent chapters.  
 
1.1 BACKGROUND 
 
The burden of non-communicable diseases (NCD) particularly cardio–
metabolic diseases are on the increase and responsible for the majority of 
deaths in the world (WHO, 2008).  
 
The real worldwide burden of these diseases is unknown due to various 
factors such as lack of reporting, diagnostic facilities, and quality of data. It is 
estimated that expenditure related to the patterns of patients admitted of these 
conditions have been escalating exponentially due to increasing cost of 
diagnosis and management of these conditions (WHO, 2010). The prevalence 
of cardio – metabolic diseases in Africa is low in comparison to other 
continents. This could be due to poor reporting, lack of diagnostic facilities and 
quality of data (WHO, 2008).  
 
It is widely acknowledged that South Africa is faced with a quadruple burden 
of diseases namely HIV/ AIDS, other communicable diseases, trauma and 
non communicable diseases including diseases of lifestyle (such as cardio–
metabolic diseases) (Bradshaw,  Groenewald,  Laubscher, et al,  2003). The 
actual burden of non-communicable diseases (such as cardio-metabolic 
diseases) at health facility and district level is unknown.  There it is difficult to 
estimate the financial burden of these conditions on a health facility. The 
Department of Health has been allocating conditional grant for management 
of HIV/ AIDS patients but no such grant is allocated for management of 
patients with cardio-metabolic diseases. 
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1.2 JUSTIFICATION OF THIS STUDY 
Gelukspan District Hospital is situated in Mafikeng Local Municipality of Ngaka 
Modiri Molema District in the North West Province. The Hospital has 184 beds 
(including 96 adult beds for male and female wards). The majority of patients 
admitted in these two wards are for two conditions (a) HIV/ AIDS and (b) 
Cardio-metabolic diseases. The Hospital regularly analyse data related to the 
HIV/ AIDS patients for HIV/ AIDS conditional grant. The information related to 
cardio-metabolic diseases are seldom analysed by the Hospital management, 
although there is a belief within the Hospital that more than one thirds of the 
patients admitted in these two wards are due to cardio–metabolic diseases. 
 
This study is planned against this background to systematically analyse the 
routinely collected data from the Hospital information system. The results of 
the study will hopefully provide the estimation of the prevalence of these 
diseases at a health facility level and the associated cost for managing these 
conditions.  This will further improve on the clinical management by medical 
officers, allied health professionals and nursing staff including the general 
management by provincial, district and hospital management of these 
diseases in a district hospital setting. 
 
1.3 RESEARCH QUESTION 
 
What is the prevalence of cardio–metabolic diseases in a district hospital in 
the North West Province? What are the type and cost of laboratory tests 
performed for these patients at the time of admission?  . 
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1.4 STUDY OBJECTIVES 
 
1.4.1 BROAD OBJECTIVE 
 
To describe the prevalence of cardio–metabolic diseases among admitted 
adult patient in a district hospital in the North West Province during one year 
study period (from 01 April 2010 to 31 March 2011).   
 
1.4.2 SPECIFIC OBJECTIVES  
 
1. To describe the prevalence cardio-metabolic diseases among the 
patients who were admitted in the Medical wards of the Hospital during 
one year study period. 
2. To determine the profile of these patients: (a) Socio-demographic 
profile (such as age, gender, ethnicity, and hospital classification), (b) 
Clinical profile (such as diagnosis, blood pressure). 
3. To determine the type and cost of laboratory tests performed for these 
patients at the time of admission.  . 
 
1.5 SUBSEQUENT CHAPTERS 
 
So far, the background to the research has been discussed. Then, research 
question and objectives were defined in this first chapter. A brief outline of 
following chapters is described below.  
 
Chapter Two: Literature Review: The purpose of the literature review is to 
review pertinent literature and to describe the management of cardio-
metabolic diseases in a district hospital setting.  
 
Chapter Three: Research Methodology: The chapter describes the 
research methodology, study design, setting and scope and data 
management techniques used in this study. 
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Chapter Four: Presentation of Results: This chapter deals with an analysis 
of the data collected for this study relating to its aims and objectives. 
 
Chapter Five: Discussion: The findings from the review of the literature are 
incorporated in this chapter with the results obtained from the analysis in order 
to address the aims and objectives of the study. 
 
Chapter Six: Conclusions and Recommendations: This constitutes the last 
chapter of the report and derives conclusions from the research related to the 
objectives of this study, makes recommendations and advocates areas for 
future research in the field of management of cardio-metabolic diseases in a 
district hospital setting. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
8805634J  DM Moalosi 
 5 
CHAPTER 2 
LITERATURE REVIEW 
 
In this chapter, relevant literatures into management of cardio-metabolic 
diseases in district hospitals are discussed.  In addition to published literature, 
information from various unpublished sources is also reviewed.  
 
2.1 CARDIO-METABOLIC DISEASES 
 
Cardio-metabolic disease (CMD) is a disease collective that includes 
cardiovascular diseases (CVD) (ischaemic heart disease, cerebrovascular 
accident, congestive heart failure) and type 2 diabetes (Alberti, Zimmet, Shaw, 
2006). They are associated with a defined cluster of risk factors that increase 
an individual’s risk for cardiac arrest and diabetes. The International Diabetes 
Federation (IDF) published in a 2005 consensus statement for standardising 
the term worldwide with prescribed measurement values, for comparative and 
research purposes (IDF, 2006).  
 
2.2 PREVALENCE OF CARDIOMETABOLIC DISEASES 
 
Contrary to the popular belief, nearly 80% of NCD deaths occur in low-and 
middle-income countries and are the most frequent causes of death in most 
countries, except in Africa (Yach, Hawkes, Gould, et al., 2004; WHO, 2008). 
Even in African nations, NCDs have been rising rapidly and are projected to 
exceed communicable, maternal, perinatal, and nutritional diseases as the 
most common causes of death by 2030 (WHO, 2008). Globally, 58 million 
deaths of all causes occurred in 2005. Thirty percent of these deaths were 
attributed to cardiovascular diseases. Amongst these, 80% of these 
cardiovascular disease occurred in low- and middle-income countries and 
deaths occur equally across males and females (WHO, 2005). The burden of 
cardiovascular diseases is expected to increase. By 2030, the four leading 
causes of mortality are expected to be ischaemic heart disease, 
cerebrovascular disease, chronic obstructive pulmonary disease and 
respiratory disorders. There is an expected increase in mortality attributable to 
8805634J  DM Moalosi 
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tobacco use, from 5.4 million in 2004 to 8.3 million in 2030, this would 
therefore represent approximately 10% global mortality (WHO, 2008). With an 
increase in risk factors and a less than optimal access to health care and 
preventive interventions, cardiovascular disease is the number one cause of 
mortality in the developing world and expected to continue as such (Gazino, 
2007). Barring Sub-Saharan Africa where is the second leading cause after 
HIV/AIDS (Jamison, Joel, Breman, Measham Ar, et al, 2006). 
 
In South Africa, the burden of non-communicable diseases are increasing 
both in rural and urban areas most prominently in poor people living in urban 
settings (Mayosi, Flisher, Lalloo, et al., 2009). The North West Province a 
rural province in South Africa, identified cardiometabolic disease to be the 
cause of approximately 22% of all causes of death, according to the 2011 
death notifications (Table 1.1).    
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Table 1.1.  The ten leading underlying natural causes of death in North 
West Province of death occurrence, 2011  
Causes of death (based on ICD10) North West 
  Rank Number Percentage 
Tuberculosis 1           4 235  11% 
Diabetes mellitus 9           1 168  3% 
Cerebrovascular disease 4           1 740  5% 
Ischaemic heart disease 
               
-                    -    0% 
Human immunodeficiency virus [HIV] disease 
               
-                    -    0% 
Chronic lower respiratory disease 10              981  3% 
respiratory 
               
-                    -    0% 
Malignant neoplasm of digestive organs 
               
-                    -    0% 
Malignant neoplasm of respiratory and intrathoracic 
organs 5           1 706  5% 
Hypertensive disease 3           2 196  6% 
Other forms of heart disease 2           3 149  8% 
Influenza and pneumonia 6           1 549  4% 
Intestinal infectiuos disease 7           1 360  4% 
Other viral diseases 8           1 264  3% 
Certain disorders involving the immune machanism 
               
-                    -    0% 
Other natural causes 
               
-           15 445  41% 
Non natural causes 
               
-              2 762  7% 
ALL CAUSES          37 555  100% 
 
Source: (Statistics South Africa, 2014, Mortality and causes of death in 
South Africa,2011: Findings from death notification).  
 
2.3 RISK OF CARDIO-METABOLIC DISEASES 
 
Apart from insulin resistance and central obesity, genetics, physical inactivity, 
ageing, pro-inflammatory states and hormonal fluctuations play a role in the 
causation of the metabolic syndrome (MS). Currently; there is scarcity of data 
describing the influence of ethnicity on the pathogenesis of cardio-metabolic 
diseases in the South African community (Yach, et al, 2004; IDF, 2006). 
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The WHO (2011) developed a 4 X 4 matrix based on the fact that people who 
die prematurely from non-communicable diseases die from preventable heart 
disease, strokes, diabetes, cancers and asthma as a result of increased levels 
of exposure to tobacco use, unhealthy diets, physical inactivity and the 
harmful use of alcohol; and ineffective and inequitable health care services for 
people with non-communicable diseases (Figure 2.1) 
 
Figure 2.1 NCD: 4 diseases, 4 modifiable risk factors 
 
 
2.4 MANAGING CARDIO-METABOLIC DISEASES  
 
The management of these risk factors and diseases still focus largely on 
lifestyle changes, namely weight loss, increased physical activity, healthy 
diets, and smoking cessation (Independent Blue Cross, 2009). The prevention 
and management of CMD requires modifying dietary and lifestyle risk factors 
(Willet, 2002; Jamison, et al, 2006). These cost-effective interventions have 
been and can be adapted for each sphere of required prevention strategy.  
 
In May 2009, a global alliance of non-governmental organizations (NCD-
Alliance) was launched by the global Non-Communicable Diseases (NCD) 
focussed organizations. Their mandate is to represent population afflicted with 
a number of NCDs both in developing and developed countries. Preceding the 
United Nations Summit on Non-communicable Diseases in September 2011, 
the NCD Alliance’s vision for the outcome of the summit include: NCD national 
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plans for all, a tobacco free world, improved lifestyles, strengthened health 
systems, global access to affordable and good quality medicines and 
technologies and finally human rights for people with NCDs (NCD Alliance, 
2010). 
 
The importance is therefore to ensure that NCDs are researched and 
quantified at relevant levels of care where action is sought and required. 
These data are beneficial in the identification of the population’s specific 
health needs and therefore focus evidence towards strengthening health 
capacity as highlighted by both NCD Alliance and the Disease Control 
Priorities Project (Jamison, et al, 2006; NCD Alliance, 2011), which are 
essential in the decision making process of good quality medicines and 
technologies development and procurement and the overall management of 
cardio-metabolic disorders.  
 
WHO (2010) suggested that the global epidemic of NCDs can be reversed 
through modest investments in interventions. These interventions include 
reduction in the major behavioural risk factors: tobacco use, harmful use of 
alcohol, unhealthy diet and physical inactivity. However, they would require 
high levels of commitment, good planning, community mobilization and 
intense focus on a small range of critical actions. The population-wide 
approach should be complemented by health-care interventions for individuals 
who either already have NCDs or those who are at high risk (WHO, 2000).  
This was supported by Kraushaar and Krämer (2009) who suggested three 
strategies namely (a) the disbanding of screening in favour of population-wide 
enrolment into preventive interventions, (b) the substitution of the current cost 
utility analysis for a return-on-investment cantered appraisal of interventions, 
and (c) the replacement of standardized programs modelled around acute 
care by individualized and perpetual interventions. 
 
2.5 COST OF MANAGING CARDIO-METABOLIC DISEASES 
 
Cardiovascular disease cost the European Union €169 billion in 2003 (Leal, 
Luengo-Fernbndenz, Gray, et al, 2006). The data from the United States of 
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America estimates that CVD costs approximately double that, in direct and 
indirect annual costs. The high cost of cardio-metabolic diseases is also 
incurred in the treatment and management of diabetes and its complications, 
where globally the expenditure approximated US dollar (USD) 376 billion in 
2010 and in 2030 the cost could exceed USD 490 billion (Thom, Haase, 
Rosamond, et al, 2006). There was an inequity of cardio-metabolic 
expenditure. Eighty percent of the world’s diabetics live in low- and middle 
income countries, 80% of the global expenditure on health care for these 
diseases occurs in the worlds economically richest countries (Zhang, Zhang, 
Brown, et al., 2010). In South Africa, one quarter of the country’s health care 
spending is devoted to cardiovascular disease (Leeder, Raymond, Greenberg, 
et al, 2004). The economic burden is not only felt at the country level, but so 
too by those afflicted with the disease, and as well as their caregivers 
(Gaziano, 2005). The Centre for Global Health and Economic Development 
estimate in countries like Brazil, India, China, South Africa, and Mexico, 21 
million years of future productive life are lost each year because of 
cardiovascular disease (Leeder, et al, 2004). 
 
The majority of these studies estimated the cost at macro level. However 
studies are necessary to estimate the financial burden placed on the health 
facilities for management of patients with these conditions.  
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CHAPTER 3 
METHODOLOGY 
 
The methodology for this study was selected on the basis of its aims and 
objectives.  In this chapter the following were discussed: setting, scope, and 
study design and research tools and data management. 
 
3.1 STUDY DESIGN 
 
A cross-sectional study design was used for this study. Retrospective record 
review was done and information was extracted from Gelukspan District 
Hospital.     
 
3.2 SETTING OF THE STUDY   
 
The setting of the study was in the adult Medical wards at the Gelukspan 
District Hospital in the North West Province. The Hospital is situated in the 
Mafikeng Local Municipality in the Ngaka Modiri Molema District in the North 
West Province (Figure 3.1). 
 
 
Figure 3.1 Map of the Ngaka Modiri Molema District 
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Gelukspan District Hospital is situated 55 kilometres from Mafikeng town, has 
350 approved beds and 184 usable beds. The Hospital has two adult general 
wards with a bed capacity of 96. The Hospital serves the population of about 
151, 444 from parts of Mafikeng, Ratlou, and Tswaing Local Municipalities 
which are largely rural and the unemployment rate of Ngaka Modiri Molema 
District is estimated at over 33,9% (Statistics South Africa, 2011).  
 
The feeder clinics for the Hospital are most far removed from the Hospital, 
the nearest clinic is 22km away from the Hospital and the furthest is more 
than 130 km.  
 
3.3 SCOPE OF THE STUDY 
 
All records of patients who were admitted in the Adult Medical Wards of the 
Gelukspan District Hospital during the one year study period were reviewed. 
The information to be used for the study was the routinely collected by the 
Hospital. Therefore, no primary data collection was done. No intervention was 
done as a part of this study. 
 
3.4 STUDY POPULATION AND SAMPLE 
 
The study population included records of all patients with cardio-metabolic 
disorders (approximately 600) who were admitted in the Gelukspan District 
Hospital during the one year study period (from 01 April 2010 to 31 March 
2011). A periodic sampling was used as the entire study population was 
included.   
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3.5 DATA MANAGEMENT 
 
3.5.1 DATA COLLECTION 
 
The data to be used for this study was extracted from different sources 
described below:  
 For Objectives 1 and 2: The patient related data to be used for this study 
was routinely collected on monthly basis as a part of PAAB and District 
Health Information System (DHIS). 
 For Objective 3: The laboratory data was extracted from the NHLS DISA 
data base. 
Data from various sources was extracted to MS excel for further analysis.  
 
3.5.2 STUDY INSTRUMENT 
 
MS Excel-based data collection tools were designed for this study. (Appendix 
B). 
 
3.5.3 STUDY VARIABLES 
 
Data was collected on various variables that are relevant to this study (Table 
3.1)  
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Table 3.1 Relevant objectives and study variables 
Objectives   Variables 
1 Prevalence of cardio-
metabolic diseases 
Number of patients admitted per 
diseases category 
2 Demographic  
 
 
 
Socio-economic  
 
Clinical profile 
 
Age 
Gender 
Ethnicity 
 
Occupation (employed/ Unemployed) 
 
Blood Pressure  on admission 
Diagnosis 
Outcome (discharge/death/transfer) 
Length of stay 
 
3 
 
Laboratory tests  
 
 
 
Blood sugar (Random and Fasting/ 
Blood HbA1C 
Blood cholesterol 
Creatinine 
Costs Cost of Laboratory tests 
 
 
The clinical parameters reported in the study (such as systolic blood pressure, 
diastolic blood pressure, random and fasting blood sugar) were measured at 
the time of admission.  
 
3.5.4 DATA ANALYSIS 
 
Data was captured on to the MS excel spreadsheet collected for the three 
objectives of study and were analysed with NCSS software (NCSS, 2007). 
The findings of the data were presented as Tables and graphs where 
appropriate.  
Following descriptive data analysis were used for the study:  
 Continuous variables (such as age): Mean or median and standard 
deviation or inter-quartile range based on the distribution of the data 
 Categorical variables (such as ethnicity and gender): and proportions.  
 
 
 
 
8805634J  DM Moalosi 
 15 
Following analytical statistics will be used to compare the variables between 
male and female patients: 
 Continuous variable with normal distribution (such as age): t-test  
 Continuous variable without normal distribution: Mann Whitney’s U 
Test  
 Categorical variables: Chi-square test 
 
In addition, test of association was done between two variables (Pearson’s or 
spearman’s correlation based on the distribution of the data).  
 
The statistical significance will be calculated at the 95% confidence level.   
 
 
3.6 ETHICAL CONSIDERATIONS 
 
All the information was collected anonymously from the Hospital Information 
System. No patient names or hospital numbers were used. Study numbers 
were allocated to different patients. The raw data from where the information 
was extracted was only available to the researcher.  
 
Permission to conduct the research at the Hospital had been obtained from 
the North West Department of the Health. The research was also approved by 
the University of the Witwatersrand ‘Human Research Ethics Committee 
(Medical) before commencement of the study (Appendix A).  
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CHAPTER 4 
RESULTS OF THE STUDY 
 
This chapter deals with the analysis of the data collected for this study relating 
to its aims and objectives.  The results obtained from the analysis of data 
were described in this chapter. 
 
4.1 NUMBER OF ADMISSIONS 
 
Number of admissions in male and female medical wards for non-
communicable diseases is listed in Table 4.1. The total number of subjects 
was 558.  
 
Table 4.1 Number of admissions per month 
 Month Total Female Ward GB3 Male Ward GB4 
April 80 24 56 
May 41 23 18 
June 47 30 17 
July 59 32 27 
August 12 11 1 
September 27 15 12 
October 62 32 30 
November 45 16 29 
December 49 27 22 
January 36 21 15 
February 40 26 14 
March 60 30 30 
Total 558 287 271 
 
The total population of patients admitted to both male and female wards is 2, 
494 patients. The admissions for cardio – metabolic disease is 22, 4% of the 
total patient population for the year of the study. 
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Figure 4.1 Admissions per Month 
 
4.2 SOCIO-DEMOGRAPHIC PROFILES 
 
4.2.1 AGE 
 
Age frequency of subjects is listed in Table 4.2 (Figure 4.2). 
 
Table 4.2 Age Frequencies of subjects 
 Total Female Male 
Median  56 58 56 
IQR 41-68 44-70 38-67 
Minimum  13 13 13 
Maximum 97 97 95 
AGE-GROUP    
Less than 50 years 201 (36.0%) 96 (33.6%) 105 (38.6%) 
50 – 64 years 165 (29.5%) 83 (29.1%) 81 (30.0%) 
65 years and more 192 (34.5%) 107 (37.4%) 85 (31.5%) 
Total  558 (100%) 287 (100%) 271 (100%) 
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There was no significant difference between male and female in terms of age 
(Mann Whitney’s U test, p = 0.04). The majority of patients were aged above 
fifty years picking at 60 years before it drops. The age – group analysis 
showed almost a third of the subjects were below 50 years age and another 
third was above 65 years of age. 
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Figure 4.2 Age Frequency 
 
4.2.2 ETHNICITY 
 
The ethnicity frequency of subjects is listed below in Table 4.3. 
 
Table 4.3 Ethnic groups  
Ethnicity TOTAL FEMALE MALE 
BLACK 546 (97.8%) 280 (97.6%) 266 (98.2%) 
INDIAN 2 (0.4%) 0 (0.0%) 2 (0.7%) 
WHITE 10 (1.8%) 7 (2.4%) 3 (1.1%) 
Total 558 (100.0%) 287 (100.0%) 271 (100.0%) 
 
There was no significant difference between male and female in terms of 
ethnicity (Chi-square test, p = 0.17). Most of the patients in the hospital were 
black. 
 
 
 
Frequency 
Age 
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4.2.3 MARITAL STATUS 
 
Marital status of subjects is listed below in Table 4.4 
 
Table 4.4 Marital status of subjects 
MARITAL STATUS TOTAL FEMALE MALE 
Divorced 2 (0.4%) 0 (0.00%) 2 (0.7%) 
Married 206 (36.9%) 83 (28.9%) 123 (45.4%) 
Single 309 (55.4%) 182 (63.4%) 127 (46.9%) 
Widow 41 (7.3%) 22 (7.7%) 19 (7%) 
Total 558 (100%) 287 (100.0%) 271 (100.0%) 
 
There was significant difference between male and female in terms of marital 
status (Chi-square test, p < 0.001). There were more single women than men. 
Patients seen in the period were mostly single (55.4%) followed by married 
(36%). 
 
4.2.4 EMPLOYMENT STATUS 
 
The employment status of subjects is listed below in Table 4.5 
 
Table 4.5 Employment status  
Occupation Total FEMALE MALE 
EMPLOYED 4 (0.7%) 2 (0.7%) 2 (0.7%) 
PENSIONER 120 (21.5%) 35 (12.2%) 85 (31.4%) 
SCHOLAR 10 (1.8%) 1 (0.3%) 9 (3.3%) 
SELF EMPLOYED 4 (0.7%) 0 (0.0%) 4 (1.5%) 
UNEMPLOYED 420 (75.3%) 249 (86.8%) 171 (63.1%) 
Total 558 (100.0%) 287 (100.0%) 271 (100.0%) 
 
There was a significant difference between male and female in terms of 
occupational status (Chi-square test, p < 0.001). There were more pensioner 
men than women.  
 
4.3 CLINICAL PROFILES 
 
4.3.1 PRIMARY CLINICAL DIAGNOSES 
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Clinical diagnoses of subjects are listed below in Table 4.6. 
 
Table 4.6 Clinical diagnoses 
Diagnosis Total FEMALE MALE 
ANGINA PECTORIS 2 (0.4%) 2 (0.7%) 0 (0.0%) 
CCF 122 (21.9%) 47 (16.4%) 75 (27.7%) 
ISCHAEMIA 10 (1.8%) 5 (1.7%) 5 (1.8%) 
HYPERTENSION 129 (23.1%) 60 (20.9%) 69 (25.5%) 
CEREBROVASCULAR 1 (0.2%) 1 (0.3%) 0 (0.0%) 
CVA 69 (12.4%) 50 (17.4%) 19 (7%) 
ENCEPHALOPATHY 6 (1.1%) 3 (1.0%) 3 (1.1%) 
DVT 7 (1.3%) 4 (1.4%) 3 (1.1%) 
CHOLESTEROL 1 (0.2%) 0 (0.0%) 1 (0.4%) 
DIABETES 211 (37.8%) 115 (40.1%) 96 (35.4%) 
Total 558  
(100.0%) 
287  
(100.0%) 
271 (100.0%) 
 
Cardio-vascular problems were the main cause of admissions. However, 
Diabetes Mellitus was the single most common cause of admission among the 
study cohort. There was no significant difference between male and female 
patients in terms of primary clinical diagnoses.  
 
4.3.2 SYSTOLIC BLOOD PRESSURE (SBP) 
 
Systolic Blood Pressure of subjects at the time of admission is listed below in 
Table 4.7. The SBP was not normally distributed (Figure 4.3).  
 
Table 4.7 Systolic Blood Pressure 
BP In mm  Total Female Male 
Median  118 118 117 
IQR 100-132.5 100-135 108-131 
Minimum  60 60 74 
Maximum 216 216 194 
 
There was no significant difference between male and female study cohorts in 
terms of Systolic Blood Pressure (SBP) (Mann Whitney’s U test, p = 0.89). 
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Figure 4.3 Systolic Blood Pressure (SBP) 
 
4.3.3 Diastolic Blood Pressure (DBP) 
 
 
Total Male Female 
SBP no of Males + Females > 
150 37 (7%) 10 (3, 69%) 27 (9, 408%) 
DBP no of Males + Females > 
90 46 (8%) 9 (3, 321%) 37 (12, 892%) 
Total 83 (15%)         19 (7%)          642 (22%) 
 
Patients with abnormal BP  are 15% of the total study cohorts. The study 
revealed that investigations did not comply to the protocol where BP for less 
than 1 patient in ten with these conditions was taken. 
 
Diastolic Blood Pressure of subjects at the time of admission is listed below in 
Table 4.8. The DBP was not normally distributed (Figure 4.4). Thirteen 
percent of the subjects (n=73) had BP more than 140/90.  
 
Table 4.8 Diastolic Blood Pressure 
BP in mm  Total Female Male 
Median  72 71 73 
IQR 61.5 - 89 56- 90 65-84 
Minimum  60 29 25 
Maximum 216 131 128 
Frequency 
SBP 
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There was no significant difference between male and female subjects in 
terms of Diastolic Blood Pressure (SBP) (Mann Whitney’s U test, p = 0.38).  
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Figure 4.4 Diastolic Blood Pressure (DBP)  
 
4.3.4 CLINICAL OUTCOME 
 
Clinical outcome are of subjects is listed below in Table 4.9. 
 
Table 4.9 Clinical outcome of subjects 
Clinical outcome Total FEMALE MALE 
DECEASED 105 (19.5%) 48 (17.9%) 57 (21.0%) 
DISCHARGE 427 (79.2%) 218 (81.3%) 209 (77.1%) 
Referred to regional hospital 7 (1.3%) 2 (0.7%) 5 (1.8%) 
Total 539 (100.0%) 268 (100.0%) 271 (100.0%) 
 
There was no significant difference between male and female in terms of 
clinical outcomes (Chi-square test, p = 0.32).  
 
4.3.5 LENGTH OF STAY 
 
The length of stay of subjects is listed below in Table 4.10. Length of stay was 
not normally distributed (Figure 4.5).  
 
 
Frequency 
DBP 
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Table 4.10 Length of Stay 
In days Total Female Male 
Median  4 4 3 
IQR 2-6 3-6 1-6 
Minimum  1 1 1 
Maximum 41 26 41 
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Figure 4.5 Length of Stay 
 
There was significant difference between male and female in terms of length 
of stay (Mann Whitney’s U test, p = 0.04). Female subjects were staying 
longer than male. 
 
Nearly fifty percent (n=271, 48%) of the subjects stayed more than 3 days. 
Thirty-nine percent of the males (n=108) and 56% (163) females stayed more 
than 3 days (the norms of average length of stay for District hospitals) 
(National Department of Health, 2002). 
 
4.4 LABORATORY TESTS 
 
The laboratory tests done at the time of admission included random and 
fasting blood glucose, and creatinine. Interestingly no HbA1C, lipogram and 
other renal function tests were done at the time of admission.  
 
Frequency 
ALoS 
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4.4.1 RANDOM BLOOD GLUCOSE 
Random blood glucose of subjects at the time of admission is listed below in 
Table 4.11 and 4.12. The random blood glucose values are not normally 
distributed (Figure 4.6). 
 
Table 4.11 Fasting Glucose 
 
Total Male Female 
Random Glucose no of Males + 
Females < 11,0 12 (2,150%) 6 (2,214%) 6 (2,090%) 
Random Glucose no of Males + 
Females > 11,0 21 (4%) 5 (1,845% ) 16 (5,575%) 
Random Glucose Total 33 (6%) 11 (4, 06%) 22 (8, 67%) 
 
Patients with random Glucose investigation are 6% of Total study cohorts. 
The study revealed that investigations did not comply to the protocol where 
BP for less than 1 patient in ten with these conditions was taken. 
 
Table 4.12 Random Glucose  
In mmol/L  Total Female Male 
Mean 12.1 13.3 9.7 
SD 7.3 7.2 7.1 
Minimum  3.1 3.2 4.1 
Maximum 30 25.6 25.8 
 
There was no significant difference between male and female in terms of 
Random Blood Glucose (t-test, p = 0.09).  
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Figure 4.6 Random Glucose  
 
Fifty percent of the patients who were tested for random blood sugar at the 
time of admission had random blood sugar more than 11.1 mmol/l (SEMDSA, 
2012).  
4.4.2 FASTING GLUCOSE 
 
Fasting glucose of subjects at the time of admission is listed below in Table 
4.12. The fasting blood glucose values are not normally distributed (Figure 
4.7). 
Table 4.12 Fasting Glucose 
 
Total Male Female 
Fasting Glucose no of Males + Females < 
6,0  39 (7%) 
13 
(4,797%) 26 (9,059%) 
Fasting Glucose no of Males + Females > 
6,0 (Pre- Diabetes)  9 (2%) 
 2 
(0,738%)  7 (2,439%) 
Fasting Glucose no of Males + Females > 
7,0 (Diabetes) 58 (10%) 
 7 (2,583% 
)  
51 
(17,770%)  
Fasting Glucose Total 106 (19%) 22 (3%) 84 (29%) 
Research Total 558        271         287  
 
Patients with random Glucose investigation are 6% and those with fasting 
Glucose investigations are 19% of Total study cohorts. The study revealed 
that investigations did not comply to the protocol where BP for less than 1 
Percent 
Glucose 
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patient in ten with these conditions was taken. 
 
Table 4.12 Fasting Glucose 
In mmol/L Total Female Male 
Median  8.4 9.0 6.5 
IQR 5.9- 16.5 5.9 – 19.6 5.4-9.9 
Minimum  3.2 3.2 4.1 
Maximum 44.0 44.0 29.1 
 
There is significant difference between male and female in terms of Fasting 
Glucose (Mann Whitney’s U test, p = 0.0006). More than 50% of subjects had  
Fasting plasma glucose (FPG) 7.0 mmol/L (SEMDSA, 2012). 
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Figure 4.7 Fasting Glucose 
 
4.4.3 CREATININE 
 
Creatinine frequency of subjects is listed below in Table 4.13. The creatinine 
values were not normally distributed (Figure 4.8). Fourteen percent of the 
subject had creatinine more than 100 μmol/L [reference range 60 μmol/L to 
100 μmol/L (NHLS, 2013)]. 
 
 
 
 
Percent 
Glucose 
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Table 4.13 Creatinine 
In mm  Total Female Male 
Median  66 63 76 
IQR 50-89 45-89 57.5 - 89 
Minimum  19 19 21 
Maximum 383 383 205 
 
There was significant difference between male and female in terms of Serum 
creatinine (Mann Whitney’s U test, p = 0.0006). Male patients had higher 
serum creatinine than female.  
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Figure 4.8 Creatinine  
 
4.4.4 LABORATORY COSTS 
 
The laboratory costs for these subjects are listed in Table 4.14. The total and 
average costs were R 90,697.94 and R162.54 respectively.  
 
 
 
 
 
 
 
 
Percent 
Creatinine 
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Table 4.14 Laboratory cost for management of cardio-metabolic 
patients  
Month Total NHLS 
April 80 4,745.40 
May 41 6,609.62 
June 47 8,166.10 
July 59 7,155.46 
August 12 7,777.51 
September 27 8,691.15 
October 62 8,878.63 
November 45 4,661.48 
December 49 5,069.71 
January 36 10,213.11 
February 40 9,368.17 
March 60 9,361.60 
Total 558 90,697.94 
 
The laboratory costs were regressed against the number of monthly 
admissions (spearman’s correlation was -0.32, p< 0.001) (Figure 4.9). It 
showed that there was a significant decrease in laboratory costs in relation to 
admission during the 12 months period.  
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Figure 4.9 Laboratory costs and monthly admissions  
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CHAPTER 5  
DISCUSSIONS 
 
In this chapter, the results obtained from the analysis of the data were 
discussed and compared with those from other published studies. 
 
5.1 STUDY POPULATION 
 
The admission for both males and females decreased significantly during the 
month of August and September 2010 probably due to the public service 
strike.  
 
5.2 SOCIO-DEMOGRAPHIC PROFILES 
 
The result showed that both males and females suffered equally from cardio-
metabolic diseases (Mann Whitney’s U test, p = 0.04). The majority of patients 
were aged above fifty years. The age – group analysis showed almost a third 
of the subjects were below 50 years age and another third was above 65 
years of age.  Therefore, the target group for improvement of management of 
these categories of patients should include the younger population as well 
older patients (<50 years).  
 
The majority of the subjects were black (97.8%) and unemployed (98%) 
representing the demographics of the catchment population. Most of them 
were single (55.4%) followed by married (36.9%). There were more single 
women than men. More than 20% of the population were pensioners 
representing the age distribution of the study cohort. There were more 
pensioner men than women. 
 
5.3 CLINICAL PROFILES 
 
There was no significant difference between male and female patients in 
terms of primary clinical diagnoses. Cardio-vascular problems were the main 
cause of admissions. However, diabetes mellitus was the single most 
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common cause of admission among the study cohort. In addition nearly a 
quarter of the patients were admitted for hypertension. This is probably due to 
the failure of the PHC facilities to manage the diabetic patients. There is a 
need to address this issue through outreach programme supported by this 
hospital.  
 
Although 23% of the patients were admitted for hypertension, only thirteen 
percent of the subjects (n=73) had BP more than 140/90. Therefore it was not 
clear why additional 10% of patients were admitted with a primary diagnosis of 
hypertension.   
 
Nearly fifty percent (n=271, 48%) of the subjects stayed more than 3 days. 
Thirty-nine percent of the males (n=108) and 56% (163) females stayed more 
than 3 days (the norms of average length of stay for District hospitals 
(National Department of Health, 2002). Subjects are admitted more days in 
hospital probably because of poor management of subjects or poor adherence 
to treatment and advice necessitating admission of patient in critical condition. 
This would require further study to understand the determinants of increasing 
length of stay in the female ward. 
 
The case fatality rate was 19.5% probably high in a district hospital setting. 
This implies that probably these patients were not managed properly at the 
PHC level or at this Hospital. However this rate is lower than a study 
conducted by Gaziano, (2007). High discharge rate might be associated with 
readmission.  Therefore, there is a need to conduct further research to 
calculate the rate of readmission 
 
5.4 LABORATORY TESTS 
 
The laboratory tests done at the time of admission included random and 
fasting blood glucose, and creatinine. Interestingly no HbA1C, lipogram and 
other renal function tests were done at the time of admission contray to the 
norms and guidelines for management of cardio-metabolic diseases (National 
Department of Health, 2006; SEMDSA, 2012). This needs further exploration 
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with the medical management at the Hospital. The hospital management may 
need to explore the possibility of training the doctors on national guidelines for 
non-communicable diseases.  
 
Fifty percent of the patients who were tested for random and fasting blood 
sugar at the time of admission had random blood sugar more than 11.1 
mmol/l and 7 mmol/L respectively (SEMDSA, 2012). This figure was higher 
than the number of admission due to diabetes. It is probably due to 
comorbidity of diabetes among the patients admitted with cardio-vascular 
disorders. Fourteen percent of the subject had creatinine more than 100 
μmol/L [reference range 60 μmol/L to 100 μmol/L (NHLS, 2013)], suggesting 
possible nephropathy among the subjects. 
 
The total and average costs were R 90,697.94 and R162.54 respectively. 
There was a significant reduction in per capita laboratory costs during the 
period (spearman’s correlation was -0.32, p< 0.001).  
 
5.5 LIMITATIONS OF THE STUDY 
 
The main limitation of the study was missing records. In these cases, ward 
registers and patients’ records were used to extract missing data in the 
electronic record keeping system.  Patient files were retrieved from the 
hospital filing system and gaps were filled using notes in the patient file. 
 
In addition, it was difficult to reconcile data sourced from different units/ 
organisations. For example, the admission and clinical data were sourced 
from admission registers from the medical wards in the hospitals, laboratory 
data were sourced from NHLS and financial data were collected from Finance 
Departments.  
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CHAPTER 6 
CONCLUSIONS AND RECOMMENDATIONS 
 
In this chapter, the results obtained from this study were assessed in relation 
to the aims and objectives of the study, so that appropriate conclusions can 
be drawn.  The limitations of the study are listed.  Based on the findings of the 
study, appropriate recommendations and suggestions for future research are 
included.  
 
6.1 CONCLUSIONS RELATED TO THE AIMS OF THE STUDY 
 
This was a descriptive retrospective study that looked at broad issues 
pertaining to the management of cardio–metabolic diseases in a district 
hospital in the North West Province during one year study period (from April 
2010 to March 2011).  
 
6.1.1 THE NUMBER OF SUBJECTS WITH CARDIO-METABOLIC 
DISEASES  
 
Number of admissions in male and female medical wards for non-
communicable diseases was 558. There were almost same number of female 
(n= 287) and male (271) admissions.  
 
6.1.2 DETERMINATION OF THE PROFILE OF THESE PATIENTS 
 
The result showed that both males and females suffer equally from cardio-
metabolic diseases. The age – group analysis showed almost a third of the 
subjects were below 50 years age and another third was above 65 years of 
age. More than 20% of the population were pensioners representing the age 
distribution of the study cohort. The majority of the subjects were black 
(97.8%) and unemployed (98%) representing the demographics of the 
catchment population. The majority of them were single (55.4%). There was 
no significant difference between male and female patients in terms of primary 
clinical diagnoses.  
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Thirty-nine percent of the males (n=108) and 56% (163) females stayed more 
than 3 days (the norms of average length of stay for District hospitals. The 
case fatality rate was 19.5% probably high in a district hospital setting.  
 
6.1.3 DETERMINATIONATION OF THE TYPE AND COST OF 
LABORATORY TESTS  
 
The laboratory tests done at the time of admission included random and 
fasting blood glucose, and creatinine. No HbA1C, lipogram and other renal 
function tests were done at the time of admission contrary to the norms and 
guidelines for management of cardio-metabolic diseases (National 
Department of Health, 2006; SEMDSA, 2012). The laboratory test result 
showed the possibility of significant comorbidity among the patients. Fourteen 
percent of the subject probably had nephropathy. The total and average costs 
were R 90,697.94 and R162.54 respectively. There was a significant reduction 
in per capita laboratory costs during the period (spearman’s correlation was -
0.32, p< 0.001).  
 
6.2 RECOMMENDATIONS 
 
6.2.1 FOLLOW-UP 
 
The researcher will present the findings of the study to the Hospital 
management and the health professionals involved with the management of 
these patients. Hopefully, the hospital management would use the findings of 
the study to improve management of these patients.  
 
6.2.2 FURTHER STUDIES 
 
Following studies are proposed as an extension of this project:  
- To evaluate the high rate of mortality including readmission 
- To evaluate the co morbidity among the patients admitted in the 
medical wards 
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- To evaluate the management of patients in the feeder clinics.  
- To extend the study to other wards in the Hospital  
 
6.3 SUMMARY AND CONCLUSIONS  
 
This was the first study conducted in this Hospital to systematically evaluate 
management of a particular group of patients. Hopefully, this study would 
assist the Hospital management to improve the management of patients 
admitted in this Hospital.  
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